Dutch/German life sciences company founded 1984; makes QIAgility, QIAcube HT, and BioRobot automated liquid handling and nucleic acid purification workstations.
QIAGEN N.V. is a multinational life sciences company incorporated in the Netherlands and operationally headquartered in Hilden, Germany. It was established on 29 November 1984 as a spin-off from Heinrich Heine University Düsseldorf by Metin Colpan and colleagues, initially focusing on nucleic acid purification technology. QIAGEN launched its first product, a kit for plasmid purification, in 1986, and listed on the Nasdaq in 1996, becoming the first German company to do so, before also listing on the Frankfurt Stock Exchange in 1997.
Although QIAGEN is not a robotics company in the industrial sense, it manufactures a significant portfolio of automated laboratory instruments and robotic workstations used in molecular biology, clinical diagnostics, forensic analysis, and pharmaceutical research. These systems automate liquid handling, sample preparation, and nucleic acid extraction workflows that would otherwise require extensive manual pipetting.
Key automation platforms include the QIAgility, a compact benchtop liquid-handling robot that automates PCR setup with single-channel precision pipetting; the QIAcube HT, an 8-channel automated workstation capable of processing 24 to 96 samples per run for high-throughput nucleic acid purification; and the QIAsymphony SP/AS series, which provides fully integrated automated DNA and RNA purification combined with assay setup for clinical diagnostic laboratories.
The BioRobot series, comprising the BioRobot 3000, 8000, 9600, and M48, represents QIAGEN's more comprehensive robotic workstation platforms. These systems support small-volume liquid handling, cross-contamination-free pipetting, temperature control, and fully automated plate processing, making them suitable for high-throughput research and clinical laboratories requiring minimal manual intervention.
QIAGEN's automation instruments are sold to hospitals, academic research institutions, forensic laboratories, pharmaceutical companies, and public health agencies worldwide. As of 2024, the company reported annual revenues exceeding USD 2 billion. Corporate headquarters are at Hulsterweg 82, Venlo, Netherlands, with principal operational offices in Hilden, Germany. The company employs over 6,000 people globally.
Primary type & automation activities this supplier delivers:
Contact Qiagen
WEBSITE
https://www.qiagen.comPHONE
+49 2103 29 0HEADQUARTERS
Germany
Company Facts
Founded
1984
Primary Role
Manufacturer
Company Size
-
Primary Region
Europe
Annual Sales
-
Funding Stage
-
Funding Total
-
